A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus
A Pilot, Randomized, Blinded, Controlled Study Evaluating Autologous Platelet-Rich Plasma for the Treatment of Vulvar Lichen Sclerosus
Sponsor: Jennifer R. Arthurs
A PHASE1/PHASE2 clinical study on Vulvar Lichen Sclerosus, this trial is ongoing. The trial is conducted by Jennifer R. Arthurs and has accumulated 13 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Nov 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Aug 2025 — Nov 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Apr 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE1/PHASE2
▶ Show 8 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2024 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2023 — Jan 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2023 — Dec 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2023 — Jul 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2022 — Jun 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2021 — Jun 2022 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Jennifer R. Arthurs
For direct contact, visit the study record on ClinicalTrials.gov .